Cargando…
Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles
Chemotherapy is commonly used for the treatment of lung cancer, but strong side effects and low treatment efficacy limit its clinical application. Here, extracellular vesicles (EVs) as natural drug delivery carriers were used to load conventional anticancer drug doxorubicin (DOX) and a chemosensitiz...
Autores principales: | Li, Huizhen, Xu, Wan, Li, Fang, Zeng, Ru, Zhang, Xiuming, Wang, Xianwu, Zhao, Shaojun, Weng, Jian, Li, Zhu, Sun, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741238/ https://www.ncbi.nlm.nih.gov/pubmed/34984953 http://dx.doi.org/10.1080/10717544.2021.2023697 |
Ejemplares similares
-
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
por: Guo, Lili, et al.
Publicado: (2016) -
Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin
por: Nath, Kavindra, et al.
Publicado: (2018) -
Ru(III) Complexes with Lonidamine-Modified Ligands
por: Shutkov, Ilya A., et al.
Publicado: (2021) -
The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment
por: Huang, Yaxin, et al.
Publicado: (2020) -
Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases
por: Chen, Chen, et al.
Publicado: (2022)